Chemical name: 1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine
Formula: C23H32N6O4S
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

SNOVITRA-XL

Introduction

SNOVITRA-XL, manufactured by Dharam Distributors, is a medication containing vardenafil as its active substance. It belongs to the class of medications known as phosphodiesterase type 5 (PDE5) inhibitors and is primarily used in the treatment of erectile dysfunction (ED) in adult men. This description provides an overview of SNOVITRA-XL, its characteristics, clinical applications, and considerations.

Characteristics

1. Active Substance: SNOVITRA-XL contains vardenafil, a potent PDE5 inhibitor that works by increasing blood flow to the penis during sexual stimulation. Vardenafil helps relax the smooth muscles of the blood vessels in the penis, allowing for improved erectile function and the ability to achieve and maintain a satisfactory erection.
2. Formulation: SNOVITRA-XL is available in the form of tablets, with each tablet containing a high dosage of vardenafil (60 milligrams). The tablets are formulated for oral administration and are designed to provide a potent and long-lasting effect, suitable for men with severe or refractory erectile dysfunction.

Clinical Applications

1. Erectile Dysfunction: SNOVITRA-XL is indicated for the treatment of erectile dysfunction, a common condition characterized by the inability to achieve or sustain an erection sufficient for satisfactory sexual performance. Vardenafil helps improve erectile function by enhancing blood flow to the penis, resulting in firmer and longer-lasting erections.

Considerations

1. Dosage and Administration: The recommended dosage of SNOVITRA-XL is one tablet (60 milligrams) taken orally, approximately 25 to 60 minutes before sexual activity. The tablet should be swallowed whole with a glass of water and may be taken with or without food. It is important not to exceed the recommended dosage to avoid the risk of adverse effects.
2. Effectiveness: SNOVITRA-XL has been shown to be effective in improving erectile function and increasing the likelihood of successful intercourse in men with erectile dysfunction. The high dosage of vardenafil in each tablet provides a potent and sustained effect, allowing for enhanced sexual performance and satisfaction.
3. Adverse Effects: Common adverse effects associated with SNOVITRA-XL may include headache, flushing, nasal congestion, dyspepsia (indigestion), and dizziness. These side effects are usually mild to moderate in severity and transient in nature. Patients should report any persistent or bothersome symptoms to their healthcare provider.
4. Drug Interactions: Vardenafil may interact with certain medications, particularly nitrates used to treat chest pain (angina) and alpha-blockers used to treat high blood pressure. Concomitant use of vardenafil with these medications may cause a sudden drop in blood pressure, leading to dizziness, fainting, or other cardiovascular complications.
5. Contraindications: SNOVITRA-XL is contraindicated in individuals with a known hypersensitivity to vardenafil or any of its components, as well as in patients who are taking nitrates or nitric oxide donors for chest pain or heart conditions. It should not be used in combination with other PDE5 inhibitors or alpha-blockers unless under the guidance of a healthcare provider.

Conclusion

SNOVITRA-XL, containing vardenafil as its active substance, is a potent medication for the treatment of erectile dysfunction in adult men. With its high dosage and long-lasting effect, SNOVITRA-XL offers a reliable option for improving erectile function and enhancing sexual satisfaction. However, its use should be guided by a qualified healthcare provider to ensure safe and appropriate treatment outcomes, and patients should be educated about potential side effects and drug interactions.